The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[1-(4-nitro-benzyl)-(sulfonyl-(4-methylbenzene))-ureido]-N-Hydroxy-acetamide ID: ALA52531
PubChem CID: 10550145
Max Phase: Preclinical
Molecular Formula: C17H18N4O7S
Molecular Weight: 422.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(S(=O)(=O)NC(=O)N(CC(=O)NO)Cc2ccc([N+](=O)[O-])cc2)cc1
Standard InChI: InChI=1S/C17H18N4O7S/c1-12-2-8-15(9-3-12)29(27,28)19-17(23)20(11-16(22)18-24)10-13-4-6-14(7-5-13)21(25)26/h2-9,24H,10-11H2,1H3,(H,18,22)(H,19,23)
Standard InChI Key: WEACEEZKOJLZFG-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 30 0 0 0 0 0 0 0 0999 V2000
6.0917 -7.6875 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.5667 -7.3875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5667 -6.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1375 -4.6667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0500 -6.4792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6042 -7.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0000 -6.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7875 -8.2042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3917 -7.1542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6167 -4.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5167 -6.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6625 -4.9667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1375 -4.0625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0917 -6.4792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0500 -5.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4750 -6.7792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0000 -5.8750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6042 -8.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1250 -7.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6167 -5.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0875 -4.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5667 -5.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0917 -5.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5667 -4.9667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6417 -7.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1250 -8.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6417 -8.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4750 -5.5750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1667 -8.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 10 1 0
5 3 1 0
6 1 1 0
7 11 1 0
8 1 2 0
9 1 2 0
10 21 1 0
11 5 1 0
12 4 1 0
13 4 2 0
14 3 2 0
15 5 1 0
16 7 2 0
17 7 1 0
18 6 2 0
19 6 1 0
20 23 1 0
21 24 2 0
22 15 1 0
23 22 2 0
24 22 1 0
25 19 2 0
26 18 1 0
27 25 1 0
28 17 1 0
29 27 1 0
26 27 2 0
20 10 2 0
M CHG 2 4 1 12 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 422.42Molecular Weight (Monoisotopic): 422.0896AlogP: 1.31#Rotatable Bonds: 7Polar Surface Area: 158.95Molecular Species: ACIDHBA: 7HBD: 3#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 4.25CX Basic pKa: ┄CX LogP: 1.53CX LogD: 0.57Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.34Np Likeness Score: -1.48
References 1. Scozzafava A, Supuran CT.. (2000) Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties., 43 (9): [PMID:10794702 ] [10.1021/jm990594k ]